저자들은 신우요관이행부폐색에 의한 심한 수신증이 있는 한 환아에서 2M NaCl 경구투여만으로 증상이 호전되고 폐색성 요로 병증의 교정 이후 재발되지 않는 일과성 가성저알도스테론혈증 1...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A101470600
최준기 (울산대학교) ; 한혜원 (울산대학교) ; 유한욱 (울산대학교) ; 박영서 (울산대학교) ; Choi Jun-Gi ; Hahn Hye-Won ; You Han-Wook ; Park Young-Seo
2004
Korean
KCI등재후보
학술저널
91-95(5쪽)
3
0
상세조회0
다운로드국문 초록 (Abstract)
저자들은 신우요관이행부폐색에 의한 심한 수신증이 있는 한 환아에서 2M NaCl 경구투여만으로 증상이 호전되고 폐색성 요로 병증의 교정 이후 재발되지 않는 일과성 가성저알도스테론혈증 1...
저자들은 신우요관이행부폐색에 의한 심한 수신증이 있는 한 환아에서 2M NaCl 경구투여만으로 증상이 호전되고 폐색성 요로 병증의 교정 이후 재발되지 않는 일과성 가성저알도스테론혈증 1례를 경험하였기에 보고하는 바이다.
다국어 초록 (Multilingual Abstract)
We report a 2-month-old boy who presented with severe hyponatremia and hyperkalemia secondary to ureteropelvic junction(VPJ) obstruction. By prenatal ultrasonography at 19 weeks of gestation, severe hydronephrosis was found which was confirmed postnat...
We report a 2-month-old boy who presented with severe hyponatremia and hyperkalemia secondary to ureteropelvic junction(VPJ) obstruction. By prenatal ultrasonography at 19 weeks of gestation, severe hydronephrosis was found which was confirmed postnatally Pyeloplasty was done on the 45th day of life, and fifteen days after pyeloplasty, non-bilious vomiting, decreased activity and dehydration developed. Severe hyponatremia and hyperkalemia were observed, as a result of elevated serum aldosterone and plasma renin activity. The anterior posterior pelvic diameter(APPD) and Society for Fetal Urology(SFU) grade measured showed no interval change before and after pyeloplasty. Pseudohypoaldosteronism was diagnosed, and 2M NaCl was administrated orally for 7 days. The electrolyte imbalance was corrected, and 8 weeks later, the elevated levels of aldosterone and plasma renin activity were normalized. The left hydronephrosis was improved at 5 months of age. We hereby report a transient pseudohypoaldosteronism secondary to UPJ obstruction with a review of the literature.
참고문헌 (Reference)
1 Schoen EJ, "Transient pseudohypoaldosteronism with hyponatremia-hyperkalemia in infant urinary tract infection" 167 : 680-682, 2002
2 Gabriele B, "Transient pseudohypoaldosteronism secondary to posterior urethral valves - A case report and review of the literature" 11 : 277-279, 2001
3 Rodriguez-Soriano J, "Transient pseudohypoaldosteronism secondary to obstructive uropathy in infancy" 103 : 375-80, 1983
4 Kuhnle U, "Transient pseudohypoaldosteronism in obstructive renal disease with transient reduction of lymphocytic aldosterone receptors" 39 : 152-5, 1993
5 Klahr S, "The pathophysiology of obstructive nephropathy:the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney" 23 : 219-23, 1994
6 Levin TL, "Salt-losing nephropathy simulating congenital adrenal hyperplasia in infants with obstructive uropathy and/or vesicoureteral reflux-value of ultrasonography in diagnosis" 21 : 413-5, 1991
7 Maruyama K, "Reversible secondary pseudohypoaldosteronism due to pyelonephritis" 17 : 1069-1070, 2003
8 Watanabe T, "Reversible secondary pseudohypoaldosteronism" 18 : 486-, 2003
9 Warshaw B, "Progression to end-stage renal disease in children with obstructive uropathy" 100 : 183-7, 1982
10 Avner ED, "Pediatric Nephrology" Lippincott Williams & Wilkins 554-560, 2004
1 Schoen EJ, "Transient pseudohypoaldosteronism with hyponatremia-hyperkalemia in infant urinary tract infection" 167 : 680-682, 2002
2 Gabriele B, "Transient pseudohypoaldosteronism secondary to posterior urethral valves - A case report and review of the literature" 11 : 277-279, 2001
3 Rodriguez-Soriano J, "Transient pseudohypoaldosteronism secondary to obstructive uropathy in infancy" 103 : 375-80, 1983
4 Kuhnle U, "Transient pseudohypoaldosteronism in obstructive renal disease with transient reduction of lymphocytic aldosterone receptors" 39 : 152-5, 1993
5 Klahr S, "The pathophysiology of obstructive nephropathy:the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney" 23 : 219-23, 1994
6 Levin TL, "Salt-losing nephropathy simulating congenital adrenal hyperplasia in infants with obstructive uropathy and/or vesicoureteral reflux-value of ultrasonography in diagnosis" 21 : 413-5, 1991
7 Maruyama K, "Reversible secondary pseudohypoaldosteronism due to pyelonephritis" 17 : 1069-1070, 2003
8 Watanabe T, "Reversible secondary pseudohypoaldosteronism" 18 : 486-, 2003
9 Warshaw B, "Progression to end-stage renal disease in children with obstructive uropathy" 100 : 183-7, 1982
10 Avner ED, "Pediatric Nephrology" Lippincott Williams & Wilkins 554-560, 2004
11 Husted RF, "Induction of resistance to mineralocorticoid hormone in cultured inner medullary collecting duct cell by TGF-b1" 267 : 767-75, 1994
12 Bonny O, "Disturbances of Na/K Balance:Pseudohypoaldosteronism Revisited" 13 : 2399-2414, 2002
13 Melzi M, "Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations" 14 : 56-59, 1995
The Effect of Tumor Necrosis Factor-Alpha on Glomerular Epithelial Cells in Glomerular Permeability
$Henoch-Sch\"{o}nlein$ Purpura 신염에서 Angiotensinogen M235T 유전자 다형성
알포트증후군 환자에서 안지오텐신전환효소 유전자 다형성의 의의
소아 신증후군 환자에서 Plasminogen Activator Inhibitor Type 1 유전자 다형성
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2024 | 평가예정 | 계속평가 신청대상 (계속평가) | |
2022-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | |
2021-12-01 | 평가 | 등재후보 탈락 (계속평가) | |
2019-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | |
2018-12-01 | 평가 | 등재후보 탈락 (계속평가) | |
2017-12-01 | 평가 | 등재후보로 하락 (계속평가) | |
2016-01-12 | 학술지명변경 | 한글명 : 대한소아신장학회지 -> Childhood Kidney Diseases외국어명 : Journal of the Korean Society of Pediatric Nephrology -> Childhood Kidney diseases | |
2013-01-01 | 평가 | 등재 1차 FAIL (등재유지) | |
2010-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2009-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2008-01-01 | 평가 | 신청제한 (등재후보1차) | |
2007-01-01 | 평가 | 등재후보 1차 FAIL (등재후보2차) | |
2006-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2004-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.12 | 0.12 | 0.13 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.11 | 0.11 | 0.332 | 0 |